Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molybdenum Cofactor Deficiency (MoCD)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)WithdrawnNCT00957749
What this trial is testing

Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A

Who this might be right for
Molybdenum Cofactor Deficiency Type A
Orphatech Pharmaceuticals, GmbH 10
Early research (Phase 1)Study completedNCT01894165
What this trial is testing

Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers

Who this might be right for
Molybdenum Cofactor Deficiency (MoCD)Rare Autosomal Recessive DisorderDeficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)
Origin Biosciences 24
Testing effectiveness (Phase 2)Study completedNCT02047461
What this trial is testing

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Who this might be right for
Molybdenum Cofactor Deficiency, Type A
Origin Biosciences 8
Large-scale testing (Phase 3)Study completedNCT02629393
What this trial is testing

Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

Who this might be right for
Molybdenum Cofactor Deficiency, Type A
Origin Biosciences 5